Across TCGA pan-cancer cohorts, CALB1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CALB1 data layer compared with 25 for mass-spec protein and 7 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher CALB1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CALB1 expression acts as an unfavorable survival marker.
COAD, SKCM, and BLCA are the cancer types where CALB1 Mutation most reproducibly stratifies survival.